Viking Therapeutics Inc.

(VKTX) Trade

By |

Profile

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists.

Contact Information

Website: www.vikingtherapeutics.com
Email: sdiaz@vidasp.com
Main Phone: +1 858 704-4660
Address: 12340 El Camino Real
Address 2: Suite 250
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Brian Lian
Employees: 16
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.41 $ -0.3 (-3.44%)
Last Price 8.41 Change $ -0.3 Change % -3.44 Tick N/A
Bid 8.00 Bid Size 200.00 Ask 12.23 Ask Size 300.00
Open 8.77 High 9.05 Low 8.29 Prev Close 8.71
Last Trade Volume 2.5 mi 52 Wk Hi 24.00 52 Wk Low 3.69
Market Cap 601 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 71,459,857.00 EPS (TTM) -0.46 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 9
Number of Buys 4 6
Number of Sells 3 3
Net Activity 56212 111212
Last 10 Buys Shares
J. Matthew Singleton 1,000
Stephen W. Webster 1,000
Charles A. Rowland 1,000
Lawson Macartney 1,000
Matthew W. Foehr 1,000
Matthew W. Foehr 1,000
Matthew W. Foehr 1,000
Last 10 Sell Shares
Michael Morneau 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 13 15
Low Target Price Estimate 13 13 7.5 13
Mean Target Price Estimate 14.6 14.6 9.88 14.4
Standard Deviation 1.14 1.14 2.59 0.89
Date of Most Recent Estimate 06/01/18 06/01/18 05/14/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1